Insider Trading & Ownership of Christopher Simon

Location
Braintree, MA
Summary
The estimated net worth of Christopher Simon is at least $26,268,755 dollars as of 03 Jun 2025. Christopher Simon is the President & CEO, Director of HAEMONETICS CORP and owns shares of HAEMONETICS CORP (HAE) stock worth about $26.06M. Christopher Simon is the Director of Sotera Health Co and owns shares of Sotera Health Co (SHC) stock worth about $213.5K.
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher Simon and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Christopher Simon has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $26,268,755.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: HAEMONETICS CORP ($26,055,242).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher Simon

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HAE HAEMONETICS CORP President & CEO, Director $26,055,242 30 May 2025
SHC Sotera Health Co Director $213,513 22 May 2025

Insider Transactions Reported by Christopher Simon:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .